We could not find any results for:
Make sure your spelling is correct or try broadening your search.
SEATTLE, Jan. 28 /PRNewswire-FirstCall/ -- Omeros Corporation (NASDAQ: OMER) today announced that the National Institute on Drug Abuse (NIDA) is providing support for the Company's Addiction...
SEATTLE, Nov. 19 /PRNewswire-FirstCall/ -- Omeros Corporation (NASDAQ: OMER) today announced unaudited financial results for the third quarter ended September 30, 2009. For the three months...
SEATTLE, WA, Nov. 13 /PRNewswire-FirstCall/ -- Omeros Corporation (NASDAQ: OMER), a biopharmaceutical company committed to discovering, developing and commercializing products focused on...
SEATTLE, Wash., Oct. 7 /PRNewswire-FirstCall/ -- Omeros Corporation today announced the pricing of its initial public offering of 6.82 million shares of its common stock at a price of $10.00 per...
SEATTLE, Sept. 18 /PRNewswire-FirstCall/ -- Omeros Corporation today announced the launch of its initial public offering of 6.82 million shares of its common stock. Omeros is a clinical-stage...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.16 | 4.41988950276 | 3.62 | 3.99 | 3.55 | 8714 | 3.72027245 | DE |
4 | -0.42 | -10 | 4.2 | 4.48 | 3.55 | 5581 | 3.90824224 | DE |
12 | -0.19 | -4.78589420655 | 3.97 | 4.5 | 3.55 | 5417 | 4.05029106 | DE |
26 | -0.12 | -3.07692307692 | 3.9 | 4.6 | 3.55 | 6902 | 4.13442832 | DE |
52 | 0.43 | 12.8358208955 | 3.35 | 4.6 | 2.96 | 10465 | 3.72317038 | DE |
156 | 0.145 | 3.98899587345 | 3.635 | 4.6 | 2.15 | 10499 | 3.25174763 | DE |
260 | 0.08 | 2.16216216216 | 3.7 | 4.6 | 2.15 | 14782 | 3.50922459 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions